Almonty, Industries

Almonty Industries Narrows Its Listing Footprint as Shareholders Weigh a Tightening Window

Published on 08/01/2026 at 02:41 | Redaktion boerse-global.de

Almonty exits ASX by Sept 1, 2026, citing cost and liquidity; CDI holders face conversion deadlines as stock nears oversold.

Almonty Industries ASX Delisting Approved: Nasdaq and Frankfurt Remain
Almonty Industries Narrows Its Listing Footprint as Shareholders Weigh a Tightening Window Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The tungsten producer Almonty Industries is completing a sweeping consolidation of its public-market presence, with the Australian Securities Exchange now formally approving the company's exit. Trading in the company's CDIs is slated to end on August 28, 2026, with the delisting taking full effect on September 1. The move follows the company's departure from the Toronto Stock Exchange at the end of July, leaving the Nasdaq and Frankfurt as the only remaining venues for its shares.

Management has framed the Australian retreat as a matter of cost and efficiency rather than operational distress. Trading volumes on the ASX have dwindled relative to the Nasdaq, and the administrative and financial burden of maintaining a listing in Sydney no longer serves shareholder interests, the company said. The streamlining is designed to place Almonty closer to US capital markets and the defense-industry supply chains it increasingly courts—proximity that matters when your core product is conflict-free tungsten, a metal in rising demand for armaments, munitions, and electronics.

For holders of the Australian CDIs, the clock is now ticking through a defined transition schedule. A notice mailed on July 29 opened a one-month window: investors can either sell their instruments on the ASX or convert them into Nasdaq shares on a 1:1 basis, with the deadline falling on August 28. Those who miss that cutoff get a second chance through a voluntary sale facility opening September 8 and closing November 6. After the delisting, anyone seeking to trade on the open market will need a broker or custodian capable of executing orders on the Nasdaq or in Frankfurt.

The corporate restructuring, however, is unfolding against a punishing stretch for the stock itself. The shares closed Friday at CAD 15.88, down 2.70 percent on the day, and have shed nearly 29 percent over the past 30 trading days. The secondary article's data, captured just before the TSX delisting, put the shares at CAD 16.09 with a 30-day loss of 27.69 percent—figures that reflect the same accelerating slide from slightly different vantage points. The 14-day relative strength index has hovered in the low-to-mid 30s, dipping below 30 at one point this week, signaling that the stock is approaching oversold territory. By contrast, the S&P/TSX Composite index carries an RSI of 53.2, underscoring how isolated Almonty's weakness is relative to the broader Canadian market.

Should investors sell immediately? Or is it worth buying Almonty?

The stock now sits roughly 52 percent below its record high of CAD 33.35, reached in mid-April. Even so, the twelve-month picture remains remarkably strong, with gains still exceeding 200 percent—a reminder that the recent correction, however steep, comes after an extraordinary run.

Part of the selling pressure traces to a convertible bond placement that knocked roughly 20 percent off the share price. It's a familiar pattern for Almonty: similar sharp corrections followed its Nasdaq listing and again in March 2026, and in hindsight those dips proved to be favorable entry points for longer-term investors. Insider activity has added to the cautious mood. On July 2, Mark Trachuk sold around 200,000 shares at approximately USD 16.97 each—the largest insider sale in three months. Over the past twelve months, insiders have sold a net USD 6.4 million more in stock than they have bought.

Despite the turbulence, the analyst community has largely held its ground. B. Riley Financial raised its price target from USD 17 to USD 23 in March while reiterating a buy rating. DA Davidson lifted its target to USD 33, and Oppenheimer moved to USD 25 with an "Outperform" rating in June. Not everyone is convinced—Weiss Ratings reaffirmed a "Sell (D-)" in June—but the consensus sits at "Moderate Buy," built on one strong buy, four buys, and one sell, with an average price target of USD 21.88, comfortably above current levels.

Almonty at a turning point? This analysis reveals what investors need to know now.

With annualized 30-day volatility running at 88.93 percent, sharp swings are likely to persist as trading recalibrates around the Nasdaq. Whether the oversold RSI marks a near-term floor or merely a pause in the sell-off is a question that may only be answered in the first sessions following the transition. For CDI holders, the more immediate decision is binary: sell before the ASX window closes on August 28, or convert and ride out the volatility on the Nasdaq.

Ad

Almonty Stock: New Analysis - 1 August

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | CA0203981034 | ALMONTY | boerse | 69906843 |